Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Understanding what to look for in rewards programs can enhance your benefits. Explore essential factors to make informed choices.
17,647 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Tesla’s foray into robotics and AI promises upside, but it also introduces new risks for shareholders. This guide bre...
Moomoo launches a refreshed free stock promotion in March 2026, offering Nvidia shares worth up to $1,000 for new cus...
Microsoft’s AI chief predicts broad automation of office work within 18 months, a forecast senior economists say coul...
Three U.S. utility stocks are delivering reliable dividend income as rate-base growth supports earnings, offering a d...
McDonald’s shares fell toward a 52-week low even as quarterly results underscored growing global sales. Investors wei...
Micron unveils a historic plan to expand memory fabrication in the United States, led by CEO Sanjay Mehrotra. The mov...
Two clear reasons reasons give cruise line stocks may rebound as travel demand returns and operators strengthen finan...
In April, Oklo delivered a sharp rebound that captured investor attention. This in-depth look explains the catalysts,...
As Oklo enters 2026, the Q1 earnings landscape offers clues about its path to commercialization. This guide breaks do...
This article breaks down what to watch in enovix (envx) 2026 earnings, translating management comments into actionabl...
Vuzix is aiming to turn AR glasses into practical frontline tools. This guide breaks down what vuzix (vuzi) 2026 earn...